ECSP003706A - PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents
PHARMACEUTICALLY ACTIVE COMPOUNDSInfo
- Publication number
- ECSP003706A ECSP003706A ECSP003706A ECSP003706A EC SP003706 A ECSP003706 A EC SP003706A EC SP003706 A ECSP003706 A EC SP003706A EC SP003706 A ECSP003706 A EC SP003706A
- Authority
- EC
- Ecuador
- Prior art keywords
- active compounds
- pharmaceutically active
- given
- compounds
- guanosine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000004712 monophosphates Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se proporcionan compuestos de fórmula I: en la que R1, R2, R3, R4 y X tienen los significados dados en la memoria descriptiva, los cuales son útiles para el tratamiento curativo y profiláctico de un trastorno médico para el que se de sea la inhibición de una guanosín 35´´-monofosfato cíclico fosfodiesterasa (po ejemplo cGMP PDE5).Compounds of formula I are provided: wherein R1, R2, R3, R4 and X have the meanings given in the specification, which are useful for the curative and prophylactic treatment of a medical disorder for which inhibition is given. of a guanosine 35´´-cyclic phosphodiesterase monophosphate (for example cGMP PDE5).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924041.8A GB9924041D0 (en) | 1999-10-11 | 1999-10-11 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003706A true ECSP003706A (en) | 2002-05-23 |
Family
ID=10862532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003706 ECSP003706A (en) | 1999-10-11 | 2000-10-10 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Country Status (3)
| Country | Link |
|---|---|
| EC (1) | ECSP003706A (en) |
| GB (1) | GB9924041D0 (en) |
| ZA (1) | ZA200202723B (en) |
-
1999
- 1999-10-11 GB GBGB9924041.8A patent/GB9924041D0/en not_active Ceased
-
2000
- 2000-10-10 EC ECSP003706 patent/ECSP003706A/en unknown
-
2002
- 2002-04-08 ZA ZA200202723A patent/ZA200202723B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200202723B (en) | 2003-04-08 |
| GB9924041D0 (en) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26383A1 (en) | "PHARMACEUTICALLY ACTIVE COMPOUNDS" | |
| BR0004779A (en) | Pharmaceutically active compounds | |
| PT1123296E (en) | CGMP INHIBITORS PDES DERIVED FROM PYRAZOLOPYRYIDINONE FOR TREATMENT OF SEXUAL DYSFUNCTION | |
| ATE283856T1 (en) | CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS | |
| ATE298753T1 (en) | PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION | |
| CA2287552A1 (en) | Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction | |
| CA2322900A1 (en) | 2-(hetero)aryl-substituted purin-6-ones as phosphodiesterase inhibitors | |
| NZ517758A (en) | Pyrazolopyrimidines useful as therapeutic agents | |
| BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
| ATE298238T1 (en) | PYRAZOLO(4,3-D)PYRIMIDINONE COMPOUNDS AS CGMP PDE INHIBITORS | |
| PL377821A1 (en) | 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer | |
| BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
| GEP20063915B (en) | PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS AND USE THEREOF FOR TREATING p38 KINASE-ASSOCIATED CONDITIONS | |
| TR200200989T2 (en) | Pharmaceutically active compounds. | |
| CY1105390T1 (en) | THERAPEUTIC MANAGEMENT OF PULMONARY HYPERTENSION | |
| SE9701304D0 (en) | Compounds | |
| AR018162A1 (en) | SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION | |
| BR0208463A (en) | Pharmaceutically Active Compounds | |
| AP2002002462A0 (en) | Pharmaceutically active compounds. | |
| YU6396A (en) | COMBINATION OF HIV PROTEASE INHIBITORS WITH OTHER UNITS FOR HIV INFECTION THERAPY | |
| ECSP003706A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| SE9701396D0 (en) | Compounds | |
| DK0814813T3 (en) | Use of penciclovir for the treatment of human herpes virus-8 |